| Autor: |
Ponting, Jennie, Tomlin, Maggie |
| Předmět: |
|
| Zdroj: |
British Journal of Midwifery; Jan2011, Vol. 19 Issue 1, p24-31, 8p, 1 Color Photograph, 3 Graphs |
| Abstrakt: |
This article reports on an innovation within a maternity unit to introduce a fetal fibronectin, point of care test, which will aid the clinician in correctly diagnosing preterm labour. In turn, this will assist in developing an individual plan of care for each woman with suspected preterm labour, rather than treating each case with the same interventions regardless of subsequent outcomes. Fetal fibronectin (FFN) is a complex adhesive glycoprotein which can be detected in the cervico-vaginal secretions of women during pregnancy. Its concentration varies throughout pregnancy. Detectable before 24 weeks of pregnancy the concentration then dips below the minimum detectable level up to 34 weeks of pregnancy, unless the woman is in preterm labour. The FFN test was successfully introduced into clinical practice. It demonstrates that, when used appropriately on women with symptomatic suspected preterm labour, FFN testing can aid in accurate diagnosis and avoid unnecessary, costly interventions. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
